ENDV OTC
Endonovo Therapeutics, Inc.
1W: +0.0%
1M: -50.0%
3M: -50.0%
YTD: -50.0%
1Y: -50.0%
3Y: -99.6%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-03-29
Earliest Filing
2024-01-03
Latest Filing
target: 3
partner: 2
acquirer: 2
Counterparties (Filed by ENDV)
7 relationshipsCompanies named in ENDV's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Evermed Medical Enterprise Ltd | — | partner | Exclusive rights holder to market and sell SofPulse in Taiwan | 2024-01-03 | View |
| Endonovo Therapeutics, Inc. | ENDV | partner | Licensor of SofPulse technology and partner in strategic agreement | 2024-01-03 | View |
| SofPulse, Inc. | — | acquirer | Buyer acquiring SofPulse medical division assets | 2023-12-04 | View |
| Endonovo Therapeutics, Inc. | ENDV | target | Seller of SofPulse medical division assets | 2023-12-04 | View |
| PEMF HOLDINGS, LLC | — | acquirer | Buyer acquiring all shares of SofPulse, Inc. from Endonovo Therapeutics, Inc. | 2023-03-29 | View |
| Endonovo Therapeutics, Inc. | ENDV | target | Parent company of SofPulse, Inc. selling the subsidiary to PEMF HOLDINGS, LLC. | 2023-03-29 | View |
| SofPulse, Inc. | — | target | Delaware corporation and wholly owned subsidiary of Endonovo Therapeutics, Inc. being acquired. | 2023-03-29 | View |
Recent 8-K Filings (5)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2024-01-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2023-12-04 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2023-10-12 | Other Events; Financial Statements and Exhibits | View | |
| 2023-03-29 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2022-09-27 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR